BIOLIFE SOLUTIONS INC — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Roderick de Greef (CEO/Chairman) and Troy Wichterman (CFO) provided standard Sarbanes-Oxley certifications on August 6, 2026 for BioLife Solutions' Q2 2026 10-Q (period ending June 30, 2026). Both officers certified that the report contains no untrue statements, financial statements fairly present the company's condition and results, and disclosure/internal controls are effective. No significant deficiencies, material weaknesses, or fraud were disclosed.
Why this rating
Routine SOX certifications; no substantive business developments, transactions, or control issues disclosed. Boilerplate filing documents.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.